Skip to main content

Objective 3: Gyunity Oral Antihypertensives Trial (Updates from Aug-Oct 2017)

Tom Easterling of University of Washington School of Medicine (UWSM), Hillary Bracken of Gyunity Health Projects and Shuchita Mundle of the Government Medical College Nagpur presented preliminary findings of the GHP Oral Antihypertensive Trial at the PRE-EMPT Annual Meeting. Overall 894 women in Nagpur, India were enrolled. Enrollment for the trial finished on September 25, 2017, giving only 10 days before presenting. Congratulations on the extraordinary effort to quickly turn data around by the Gyunity team!